Beckman Coulter, Inc.

Beckman Coulter, Inc. US Customer Operations Division, a subsidiary of Danaher Corporation headquartered in Brea, California, sells automated clinical laboratory diagnostic equipment, reagents, consumables, and cost-per-reportable-result testing services to federal healthcare agencies as a prime contractor across 144 federal agencies on full-and-open competitive basis without set-asides.

The division operates as a manufacturer of clinical laboratory instrumentation and in-vitro diagnostic substances, delivering concrete capabilities centered on automated urinalysis, chemistry, hematology, immunoassay, and microbiology analyzers along with associated reagents, supplies, and maintenance services. Representative prime work includes a $230 thousand purchase order from Veterans Integrated Service Network 17 (August 2026) for a MALDI-TOF microbiology analyzer system with software modules and consumables for VA North Texas Healthcare System; a $3.57 million purchase order from the Bureau of Medicine and Surgery (March 2026) for maintenance and repair services on AU5800 series clinical analyzers running through March 2031; and a $2.99 million purchase order from the Defense Health Agency (October 2025) for cost-per-reportable-results services with an automated core laboratory at Fort Moore, Georgia, extending through September 2027.

Customer concentration skews heavily toward the Veterans Health Administration. The top five customer agencies by award count account for 27 percent of recent awards, with Veterans Integrated Service Network 16 leading at 1,002 awards valued at $396.6 million in combined potential value, followed by VISN 17 (423 awards, $352.7 million), VISN 4 (476 awards, $207.2 million), VISN 21 (266 awards, $133.1 million), and VISN 10 (341 awards, $122.5 million). By dollar value, the same ranking holds with VISN 16 and VISN 17 anchoring over $749 million combined; the split between award count and potential value rankings is tight, signaling consistent contract sizing across the VA footprint rather than a few large deals propping up dollar share.

Beckman Coulter holds a dominant position on the GSA Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, where 5,532 task orders carry $1.94 billion in combined potential value. The division also places work under Federal Supply Schedule V797P6553A (2,894 task orders, $172.3 million) and GS07F5359R (715 task orders, $28.2 million), along with smaller-ceiling IDIQs and single-award BPAs with specific VISNs and the Defense Health Agency. Named parent vehicles include the VISN 4 Blanket Purchase Agreement for microbiology testing ($3.1 million ceiling through November 2030), the VISN 12 BPA for urinalysis cost-per-reportable-result ($2.52 million ceiling through February 2027), the VISN 5 microbiology BPA ($700 thousand through January 2027), and the VISN 17 hematology CPRR agreement ($1.11 million through January 2027). These vehicles enable streamlined procurement across the VA's regional networks.

Activity has remained stable at 267–307 awards per year from 2022 through 2025, with 83 awards recorded through December 2026 in the source snapshot. The division faces significant recompete exposure: 245 awards carrying combined potential value of $156 million mature within the next twenty-four months, reflecting the time-bound nature of many VA blanket purchase agreements and fixed-term delivery orders typical of federal healthcare procurement cycles.

Beckman Coulter operates as a pure prime contractor in the federal space — 100 percent of its recent awards are prime contracts or IDVs, with one documented sub-award under Consolidated Nuclear Security, LLC for the Y-12 National Security Complex management-and-operating contract. The division competes full-and-open without set-aside posture across its federal footprint, reflecting its scale and established position as a critical vendor rather than reliance on small-business or socioeconomic carve-outs.

The award portfolio concentrates in laboratory instrumentation and diagnostic substance manufacturing: Analytical Laboratory Instrument Manufacturing accounts for 7,086 awards, In-Vitro Diagnostic Substance Manufacturing for 640, and equipment repair and maintenance for 518. By procurement service code, Laboratory Equipment and Supplies dominates at 3,207 awards, followed by Chemical Analysis Instruments (2,872) and In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets (2,243). This deep, dense concentration in federal healthcare diagnostics reflects Beckman Coulter's market position as the dominant supplier of automated laboratory platforms and consumables to the VA and DoD medical treatment facilities.